Provided by Tiger Trade Technology Pte. Ltd.

Design Therapeutics, Inc.

10.26
-0.0400-0.39%
Post-market: 10.260.00000.00%16:10 EDT
Volume:173.92K
Turnover:1.78M
Market Cap:632.76M
PE:-8.43
High:10.45
Open:10.18
Low:9.95
Close:10.30
52wk High:11.23
52wk Low:2.60
Shares:61.67M
Float Shares:26.28M
Volume Ratio:0.35
T/O Rate:0.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2174
EPS(LYR):-1.2174
ROE:-30.70%
ROA:-20.66%
PB:2.98
PE(LYR):-8.43

Loading ...

Design Therapeutics Initiated at Buy by Jefferies

Dow Jones
·
Mar 16

Jefferies Initiates Coverage on Design Therapeutics With Buy Rating, $15 Price Target

MT Newswires Live
·
Mar 16

U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics

Reuters
·
Mar 16

Design Therapeutics initiated with a Buy at Jefferies

TIPRANKS
·
Mar 16

Design Therapeutics Is Maintained at Outperform by RBC Capital

Dow Jones
·
Mar 10

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Design Therapeutics (DSGN) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Mar 10

Design Therapeutics price target raised to $14 from $13 at RBC Capital

TIPRANKS
·
Mar 10

RBC Raises Price Target on Design Therapeutics to $14 From $13, Keeps Outperform, Speculative Risk

MT Newswires Live
·
Mar 10

Design Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 10

Design Therapeutics reports Q4 EPS (27c), consensus (35c)

TIPRANKS
·
Mar 10

Design Therapeutics reports lower-than-expected Q4 net loss

Reuters
·
Mar 10

Design Therapeutics Q4 EPS $(0.27) Beats $(0.35) Estimate

Benzinga
·
Mar 10

BRIEF-Design Therapeutics Q4 Basic EPS USD -0.27

Reuters
·
Mar 10

Design Therapeutics FY2025 net loss rose 41% to USD 69.79 million, R&D expenses increased 33% to USD 59.13 million

Reuters
·
Mar 10

Design Therapeutics Q4 Operating Expenses USD 18.169 Million

THOMSON REUTERS
·
Mar 10

Press Release: Design Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Updates

Dow Jones
·
Mar 10

U.S. Earnings Preview: Before Market Open March 9

Dow Jones
·
Mar 09

Design Therapeutics Inc expected to post a loss of 35 cents a share - Earnings Preview

Reuters
·
Mar 06

Design Therapeutics to Present at Oppenheimer Annual Healthcare Life Sciences Conference and Leerink Partners Global Healthcare Conference

Reuters
·
Feb 18

Design Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Feb 18